German CDMO Forms “Smart” U.S. Subsidiary

06:53 EST 1 Feb 2020 | Genetic Engineering News

In the pharmaceutical industry, many products have been launched using well-established processes. But if new products are to reach greater heights, these processes must be improved. What’s needed is the boost that only smart, interconnected technologies and real-time analyses can deliver. That’s the governing philosophy behind Rentschler Biopharma building out its first U.S. site, which will be an “innovation center” focused on designer biologics.

The post German CDMO Forms “Smart” U.S. Subsidiary appeared first on GEN - Genetic Engineering and Biotechnology News.

Original Article: German CDMO Forms “Smart” U.S. Subsidiary


More From BioPortfolio on "German CDMO Forms “Smart” U.S. Subsidiary"

Quick Search

Relevant Topic

The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...